EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.5
(3.45%)
AUD 1.5
(3.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 6.96 Million AUD | 91.87% |
| 2023 | 3.62 Million AUD | 176.57% |
| 2022 | 1.31 Million AUD | -35.37% |
| 2021 | 2.03 Million AUD | 28.02% |
| 2020 | 1.58 Million AUD | 92.54% |
| 2019 | 823.81 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 571.18 Thousand AUD | -75.49% |
| 2024 Q2 | 1.14 Million AUD | 100.0% |
| 2024 Q4 | 5.82 Million AUD | 0.0% |
| 2024 FY | 6.96 Million AUD | 91.87% |
| 2023 Q2 | 1.29 Million AUD | 100.0% |
| 2023 Q3 | 1.16 Million AUD | -10.29% |
| 2023 Q1 | 649.51 Thousand AUD | -46.44% |
| 2023 FY | 3.62 Million AUD | 176.57% |
| 2023 Q4 | 2.33 Million AUD | 100.0% |
| 2022 Q1 | 49.9 Thousand AUD | -93.82% |
| 2022 FY | 1.31 Million AUD | -35.37% |
| 2022 Q4 | 1.21 Million AUD | 100.0% |
| 2022 Q3 | 606.3 Thousand AUD | 507.52% |
| 2022 Q2 | 99.8 Thousand AUD | 100.0% |
| 2021 FY | 2.03 Million AUD | 28.02% |
| 2021 Q2 | 1.22 Million AUD | 100.0% |
| 2021 Q3 | 403.83 Thousand AUD | -66.98% |
| 2021 Q4 | 807.66 Thousand AUD | 100.0% |
| 2021 Q1 | 611.47 Thousand AUD | -49.63% |
| 2020 Q3 | 606.99 Thousand AUD | 63.1% |
| 2020 Q4 | 1.21 Million AUD | 100.0% |
| 2020 Q2 | 372.14 Thousand AUD | 100.0% |
| 2020 Q1 | 186.07 Thousand AUD | 0.0% |
| 2020 FY | 1.58 Million AUD | 92.54% |
| 2019 FY | 823.81 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 229.421% |
| Acrux Limited | -5.8 Million AUD | 220.077% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 150.214% |
| BTC Health Limited | 1.05 Million AUD | -559.962% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 155.583% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 116.455% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 80.457% |
| Biome Australia Limited | -1.67 Million AUD | 516.985% |
| Hexima Limited | -933.87 Thousand AUD | 845.764% |
| Immutep Limited | -39.89 Million AUD | 117.456% |
| Memphasys Limited | -4.44 Million AUD | 256.786% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 95.566% |
| Noxopharm Limited | -3.57 Million AUD | 294.641% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 184.541% |
| Race Oncology Limited | -13.81 Million AUD | 150.397% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 114.525% |
| Starpharma Holdings Limited | -8.16 Million AUD | 185.297% |
| Tissue Repair Ltd | -4.13 Million AUD | 268.301% |
| Biotron Limited | -3.43 Million AUD | 302.661% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 136.419% |
| CSL Limited | 2.64 Billion AUD | 99.736% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 579.898% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 389.081% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 119.045% |
| Patrys Limited | -3.53 Million AUD | 296.784% |
| Orthocell Limited | -7.18 Million AUD | 196.985% |
| Imugene Limited | -149.68 Million AUD | 104.653% |
| PYC Therapeutics Limited | -37.72 Million AUD | 118.461% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 209.226% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 171.469% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 179.63% |
| Nanollose Limited | -1.15 Million AUD | 702.176% |
| Invex Therapeutics Ltd | -1.64 Million AUD | 524.196% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | -2048.141% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 254.648% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 343.146% |
| Nyrada Inc. | -1.38 Million AUD | 602.406% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | -33.65% |
| Dimerix Limited | -17.07 Million AUD | 140.787% |
| PharmAust Limited | -9.03 Million AUD | 177.106% |
| AnteoTech Limited | -8.88 Million AUD | 178.424% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 111.874% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 139.433% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 302.659% |
| Actinogen Medical Limited | -13.04 Million AUD | 153.391% |
| Immuron Limited | -6.93 Million AUD | 200.397% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 227.101% |